Analyst Price Targets — SENS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 3, 2026 2:33 pm | Jonathan Block | Stifel Nicolaus | $9.00 | $7.21 | StreetInsider | Stifel Reiterates Hold Rating on Senseonics Holdings (SENS) |
| June 2, 2025 10:11 am | Sean Lee | H.C. Wainwright | $1.10 | $0.53 | TheFly | Senseonics assumed with a Buy at H.C. Wainwright |
| July 25, 2022 6:26 am | — | H.C. Wainwright | $3.00 | $1.29 | Benzinga | HC Wainwright & Co. Maintains Buy on Senseonics Holdings, Lowers Price Target to $3 |
Latest News for SENS
The consensus price target hints at a 124.5% upside potential for Senseonics (SENS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Senseonics Holdings, Inc. (SENS) Q4 2025 Earnings Call Transcript
Senseonics Holdings (SENS) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to a loss of $0.4 per share a year ago.
Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration, with twiist in the US GERMANTOWN, Md., March 02, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development, manufacturing and commercialization of…
Senseonics rolls out Eversense 365 integrated with Sequel's twiist AID system, aiming to boost CGM adoption with its year-long wear advantage.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SENS.
U.S. House Trading
No House trades found for SENS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.